Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer

Amit M. Algotar, M. Suzanne Stratton, Frederick R. Ahmann, James Ranger-Moore, Raymond B. Nagle, Patricia A. Thompson, Elizabeth Slate, Chiu H. Hsu, Bruce L. Dalkin, Puneet Sindhwani, Michael A. Holmes, John A. Tuckey, David L. Graham, Howard L. Parnes, Lawrence C. Clark, Steven P. Stratton

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences